Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HCW Biologics Inc. Common Stock
HCWB | US
1.79
USD-0.28
-13.53%
HCWB | US
About HCW Biologics Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
1.79
Open
2.06
High
2.06
Low
1.77
HCW Biologics Inc. a clinical-stage biopharmaceutical company focuses on discovering and developing novel immunotherapies for chronic low-grade inflammation and age-related diseases. The company's lead products include HCW9218 which is an injectable immunotherapeutic for patients with pancreatic ovarian breast prostate and colorectal cancers as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases such as alopecia areata and metabolic diseases. It also develops HCW9201 a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar Florida.
View LessHCWB | US
Risk
1019.4
Sharpe
-0.24
Luna's Score
36/100
Recommendation
Sell
Luna says (HCWB | US)
What's Working
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
What's not Working
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
703.1%1 month
1019.4%3 months
622.4%6 months
453.2%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.80
Debt to equity
-1.59
Debt to assets
0.37
Ent. to EBITDA
-3.63
Ent. to rev.
7.66
PEG
-
Other Fundamentals
EBITDA
-36.58M
MarketCap
78.10M
MarketCap(USD)
78.10M
Div. yield
-
Op. margin
-2.24K
Erngs. growth
-
Rev. growth
-0.60
Ret. on equity
-344.32
Short ratio
0.87
Short perc.
0.14
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.99
Range1M
3.69
Range3M
3.74
Volumes: Market Activity
Rel. volume
0.05
Price X volume
3.05M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -3.63 | - | Cheaper |
| Ent. to Revenue | 7.66 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.80 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 622.44 | - | Riskier |
| Debt to Equity | -1.59 | -1.23 | Cheaper |
| Debt to Assets | 0.37 | 0.25 | Expensive |
| Market Cap | 78.10M | - | Emerging |
